MPLX LP vs Personalis Inc. Common Stock — how do they compare? MPLX LP trades at $57.5 (market cap $58.26B), while Personalis Inc. Common Stock trades at $16.14 (market cap $1.70B). The key difference: MPLX LP is far larger — about 34.3× Personalis Inc. Common Stock's market cap, and MPLX LP pays a 7.49% dividend while Personalis Inc. Common Stock pays none. Which is the better fit depends on your goals.
| MPLX | PSNL | |
|---|---|---|
Market Cap | $58.26B | $1.70B |
Volume | 2,089,896 | 3,262,398 |
Sector | Energy | Health |
52-Week High | $60.51 | $18.38 |
52-Week Low | $48.53 | $5.04 |
Enterprise Value | $83.36B | $1.52B |
Dividend Yield | 7.49% | — |
Typical Hold Time | — | 0 Days |
Signals from Pluang's Aura AI — not financial advice
MPLX trades at $56.91 with minimal daily movement (+0.14%). Technical indicators show a bearish trend while fundamentals remain strong with a 40.45% net income margin and 33.95% ROE. The company maintains robust cash flow generation of $5.91B from operations in 2025, supporting its $1.08 dividend. Recent earnings showed mixed results with one beat and two misses in the last three quarters.
Wall Street maintains a bullish outlook with 19 buy ratings and a $63.80 consensus price target, representing 12% upside potential. Key risks include energy market volatility and execution challenges, but MPLX's fee-based revenue model provides stability. The stock offers value at a 12.36 P/E ratio with dividend income appeal.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
MPLX LP is a Master Limited Partnership (MLP) formed by Marathon Petroleum Corporation (MPC). It is a diversified, growth-oriented company primarily engaged in the gathering, processing, and transportation of natural gas and natural gas liquids (NGLs), as well as the transportation, storage, and distribution of crude oil and refined petroleum products. MPLX owns and operates a network of midstream energy infrastructure assets, providing essential services to the energy industry across the United States.
Read more on MPLX →Personalis Inc. is a cancer genomics company that provides tumor- and blood-based DNA and RNA sequencing tests, including its NeXT Personal liquid biopsy test for cancer monitoring.
Read more on PSNL →